RESEARCHER PROFILE
Marika Pane
← Back to Università Cattolica del Sacro Cuore
M
Università Cattolica del Sacro Cuore
Marika Pane works in Neurogenetic and Muscular Disorders Research, Muscle Physiology and Disorders, Amyotrophic Lateral Sclerosis Research, Lysosomal Storage Disorders Research, Genomics and Rare Diseases. Recorded institutional associations include Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Centro Clinico Nemo.
408Publications
13,527Citations
69H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Muscle MRI in inherited neuromuscular disorders: Past, present, and future
2007 · 439 citationsThe Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability
2010 · 391 citationsRevised upper limb module for spinal muscular atrophy: Development of a new module
2016 · 347 citationsNeurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations
2015 · 332 citationsOnasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
2021 · 261 citationsReliability of the North Star Ambulatory Assessment in a multicentric setting
2009 · 231 citationsSafety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial
2021 · 228 citationsNorth Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy
2010 · 216 citationsHistological effects of givinostat in boys with Duchenne muscular dystrophy
2016 · 212 citationsPatterns of disease progression in type 2 and 3 SMA: Implications for clinical trials
2015 · 202 citationsContent validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy
2017 · 201 citationsCongenital muscular dystrophies with defective glycosylation of dystroglycan
2009 · 192 citationsMuscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy
2005 · 190 citationsAttention Deficit Hyperactivity Disorder and Cognitive Function in Duchenne Muscular Dystrophy: Phenotype-Genotype Correlation
2012 · 178 citationsFunctional changes in Duchenne muscular dystrophy
2011 · 177 citationsRandomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy
2006 · 172 citationsRevised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool
2017 · 165 citationsMuscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures
2004 · 163 citationsLong Term Natural History Data in Ambulant Boys with Duchenne Muscular Dystrophy: 36-Month Changes
2014 · 154 citationsMotor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis
2021 · 153 citationsMuscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine
2009 · 152 citationsThe NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials
2015 · 150 citationsDevelopmental milestones in type I spinal muscular atrophy
2016 · 143 citationsRevised upper limb module for spinal muscular atrophy: 12 month changes
2019 · 138 citationsFeeding problems and malnutrition in spinal muscular atrophy type II
2008 · 131 citations
